Melinta Therapeutics, Inc. Revenue per Employee (CEMP), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Melinta Therapeutics, Inc.  (CEMP)
 

Melinta Therapeutics's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Melinta Therapeutics's Revenue per employee fell on a trailing twelve month basis to $ 321,731, but the productivity of Melinta Therapeutics's employees remained above the company average.
Within the Healthcare sector Employees of 125 other companies have achieved higher revenue per employee. While Melinta Therapeutics's total ranking has deteriorated compared to the previous quarter from 0 to 1674. Melinta Therapeutics has 253 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMP Revenue per Employee (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Revenue Change -53.43 % 32.72 % -5.1 % 738.79 % 967.94 %
Sales per Employee (TTM) $ 321,731 393,700 378,154 381,146 257,597
CEMP's Total Ranking # 1674 # 0 # 0 # 0 # 0
Seq. Revenue Change -0.53 % 13.28 % -60.31 % 4.14 % 183.46 %

CEMP Company Profile >> Back to CEMP Efficiency Comparisons >> Compare CEMP Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 74
Healthcare Sector # 126
Overall Market # 1674

Revenue per Employee Statistics
High Average Low
$ 393,700 $ 114,685 $ 56,878
(Jun 30 2019)   (June 30. 2016)



Financial Statements
Melinta Therapeutics's Revenue MRQ $ 16 Millions Visit CEMP's Income Statement
Melinta Therapeutics's Revenues TTM $ 81 Millions Visit CEMP's aggregate revenue growth
What are CEMP's Sales? Visit CEMP's Sales by Segment




Other Ratios
Melinta Therapeutics's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
CEMP's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for CEMP's Competitors
Revenue per Employee for CEMP's Suppliers
Revenue per Employee for CEMP's Customers

You may also want to know
CEMP's Sales Growth Rates CEMP's Pe Price to earnings ratio CEMP's Receivables Turnover Ratio CEMP's Stock Quote
CEMP's Net Income Growth Rates CEMP's Ps Price to Sales ratio CEMP's Sales per Employee CEMP's Asset Turnover Ratio
CEMP's Net Margin CEMP's Pb Price to Book ratio CEMP's Financial Strength Ratios CEMP's Dividend Payout Ratio
Date modified: 2026-09-26T06:56:48+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2019, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2019Number of Employees Sep 30 2019
Pediatrix Medical Group Inc   533,425.32 $ 3,496.603  Million 6,555 
3m Company  528,429.75 $ 31,970.000  Million 60,500 
Sangamo Therapeutics Inc   524,042.25 $ 74.414  Million 142 
Alkermes Plc   523,892.20 $ 1,073.979  Million 2,050 
Voyager Therapeutics Inc   522,872.34 $ 73.725  Million 141 
Teva Pharmaceutical Industries Limited  514,167.89 $ 17,456.000  Million 33,950 
Cardiovascular Systems Inc   512,482.00 $ 256.241  Million 500 
Accuray Incorporated  509,929.54 $ 412.533  Million 809 
Kaya Holdings Inc   503,967.50 $ 1.008  Million 2 
Biomarin Pharmaceutical Inc  497,615.34 $ 1,602.819  Million 3,221 
Regeneron Pharmaceuticals Inc   494,594.22 $ 7,621.697  Million 15,410 
Inogen Inc   490,779.55 $ 369.557  Million 753 
Siga Technologies Inc  490,755.49 $ 24.047  Million 49 
Outlook Therapeutics Inc   479,183.71 $ 8.146  Million 17 
Halozyme Therapeutics Inc   478,862.88 $ 202.559  Million 423 
Logicmark Inc  477,194.88 $ 15.747  Million 33 
Hologic Inc  476,280.06 $ 3,367.300  Million 7,070 
Pacira Biosciences inc   474,930.04 $ 393.717  Million 829 
Rigel Pharmaceuticals Inc  469,798.85 $ 81.745  Million 174 
Zimmer Biomet Holdings Inc   466,323.53 $ 7,927.500  Million 17,000 
Iridex Corp  464,000.00 $ 43.152  Million 93 
Telesis Bio Inc   463,272.73 $ 5.096  Million 11 
Fuse Medical Inc   458,787.37 $ 23.398  Million 51 
Catheter Precision Inc   458,647.06 $ 7.797  Million 17 
Nature s Sunshine Products inc   456,444.17 $ 367.894  Million 806 
Sensus Healthcare Inc   447,247.28 $ 26.835  Million 60 
Icad Inc  447,181.82 $ 29.514  Million 66 
Fortress Biotech Inc   442,179.49 $ 34.490  Million 78 
Surface Oncology Inc   440,803.57 $ 24.685  Million 56 
Enovis Corp  438,901.69 $ 3,424.311  Million 7,802 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.